Hird, Amanda E., Diana E. Magee, Douglas C. Cheung, Rano Matta, Girish S. Kulkarni, and Robert K. Nam. “Abiraterone Vs. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: A Microsimulation Model”. Canadian Urological Association Journal 14, no. 9 (March 29, 2020): E418–27. Accessed April 19, 2024. https://cuaj.ca/index.php/journal/article/view/6234.